title: Surgical resection following combination chemotherapy with oral S-1 and biweekly docetaxel in a patient with advanced gastric cancer and a prior coronary artery bypass graft with the right gastroepiploic artery: report of a case.
abstract: Cardiothoracic surgeons commonly use the internal thoracic artery (ITA) and the right gastroepiploic artery (RGEA) when performing a coronary artery bypass graft (CABG). Although the development of CABG surgery has enabled long-term survival in patients with coronary artery disease, malignant diseases are more common in older patients. We present the case of a 75-year-old man who had previously undergone CABG with the RGEA and had later developed advanced gastric cancer. We treated this patient with two courses of combination chemotherapy using S-1 and docetaxel as induction therapy, followed by successful tumor resection. Therefore, neoadjuvant chemotherapy was effective for preserving the CABG with the RGEA in a patient with advanced gastric cancer.
authors.affiliation: Department of Surgery and Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
authors.forename: Nobuhide
authors.initials: N
authors.lastname: Kubo
authors.forename: Eiji
authors.initials: E
authors.lastname: Oki
authors.forename: Kippei
authors.initials: K
authors.lastname: Ohgaki
authors.forename: Kotaro
authors.initials: K
authors.lastname: Shibahara
authors.forename: Ichiro
authors.initials: I
authors.lastname: Imamura
authors.forename: Noriaki
authors.initials: N
authors.lastname: Sadanaga
authors.forename: Masaru
authors.initials: M
authors.lastname: Morita
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kakeji
authors.forename: Kohei
authors.initials: K
authors.lastname: Fujita
authors.forename: Shunichi
authors.initials: S
authors.lastname: Tsujitani
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Maehara
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass / Q000379:methods*; D003327:Coronary Disease / Q000150:complications / Q000601:surgery; D000077143:Docetaxel; D004338:Drug Combinations; D005500:Follow-Up Studies; D005743:Gastrectomy / Q000379:methods*; D024405:Gastroepiploic Artery / Q000601:surgery*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D020360:Neoadjuvant Therapy / Q000379:methods; D009367:Neoplasm Staging; D010094:Oxonic Acid / Q000008:administration & dosage; D011300:Preoperative Care / Q000379:methods; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000150:complications / Q000473:pathology* / Q000628:therapy*; D043823:Taxoids / Q000008:administration & dosage; D005641:Tegafur / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D043823:Taxoids; C079198:S 1 (combination); D005641:Tegafur; D000077143:Docetaxel; D010094:Oxonic Acid